DTx Commercialization and Reimbursement

 View Only

About this Group

This group works through expanding and standardizing the commercial pathways for reimbursement of DTx products. The group is working to ensure the successful adoption of the Digital Mental Health Treatment (DMHT) codes, building formulary and medical policy standards, and dissecting successful launch strategies. Also monitors and informs ATA Action policy and legislative efforts.
SIG Leader
SIG Leader

Upcoming Events


  • Friday
    14
    November

    Product Commercialization & Reimbursement SIG Meeting - November 2025

    Nov 14, 12:00:00 PM - 01:00:00 PM (ET)
    The November meeting is moving to 12p ET on Friday, November 14th. Meeting agenda : PFS Final Rule ROI Discussion – Framing value demonstration and real-world impact for stakeholders Evidence Repository for Stakeholders – Structure, content, and next steps for development Launch Playbook – Draft review and alignment on key components and distribution strategy We look forward to seeing you there!

Latest Discussions

Please login to see recent discussions.

Either the content you're seeking doesn't exist or it requires proper authentication before viewing.

Announcements

  • Welcome!

    By: Shannon Callaway Shannon Callaway , 7 months ago

    Welcome to the Digital Therapeutics Commercialization and Reimbursement SIG! We meet bi-monthly on the second Tuesday of the month at 12p Eastern Time.

    See our upcoming meetings and RSVP to a meeting to receive a calendar hold in your email.

Latest Library Entries